Table 5.
Item | Experimental group (n = 66) | Control group (n = 40) | t | P |
---|---|---|---|---|
TGF-β (μg/L) | ||||
Before treatment | 22.07 ± 2.16 | 21.93 ± 2.08 | 0.328 | 0.744 |
After treatment | 30.15 ± 3.04ab | 25.42 ± 2.47a | 8.313 | 0.000 |
IGF-1 (μg/L) | ||||
Before treatment | 83.41 ± 10.29 | 82.87 ± 9.83 | 0.266 | 0.791 |
After treatment | 95.72 ± 12.06ab | 89.64 ± 11.25a | 2.579 | 0.011 |
FGF-2 (ng/L) | ||||
Before treatment | 23.58 ± 2.47 | 24.01 ± 2.53 | 0.861 | 0.391 |
After treatment | 34.64 ± 3.59ab | 28.39 ± 2.92a | 9.298 | 0.000 |
Compared with before treatment, aP < 0.05; compared with control group, bP < 0.05. FGF-2 fibroblast growth factor-2, IGF-1 insulin-like growth factor-1, TGF-β transforming growth factor-β